Oral Supplementation of Phosphatidylcholine Attenuates the Onset of a Diet-Induced Metabolic Dysfunction–Associated Steatohepatitis in Female C57BL/6J MiceSummary

Background & Aims: Changes in phosphatidylcholine levels in the liver have been associated with the development of metabolic dysfunction–associated steatotic liver disease. Here, the effects of supplementing phosphatidylcholine on the development of early signs of metabolic dysfunction–associate...

Descripció completa

Dades bibliogràfiques

Autors principals:	Victor Sánchez, Anja Baumann, Annette Brandt, Maximilian F. Wodak, Raphaela Staltner, Ina Bergheim
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2024-01-01
Col·lecció:	Cellular and Molecular Gastroenterology and Hepatology
Matèries:	Phosphatidylcholine Inflammation MASLD Peroxisome Proliferator-Activated Receptor γ NFκB
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2352345X24000092
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!